Life Edit Therapeutics
Chuck Pepe-Ranney is a Senior Data Scientist in Computational Biology at Life Edit Therapeutics since August 2021 and an Adjunct Assistant Professor at the UNC Gillings School of Global Public Health, teaching a Data Science Basics course. Previous experience includes serving as a Data Scientist at AgBiome, where Chuck designed and led the development of the AWS Genomics Data Platform, and as a Postdoctoral Researcher at Cornell University, focusing on microbiome analysis pipelines. Additional roles include teaching at the Marine Biological Laboratory and an undergraduate internship at Idaho National Laboratory. Chuck holds a Ph.D. in Environmental Microbiology, an MS in Environmental Engineering, and a BS in Environmental Science from the Colorado School of Mines.
Life Edit Therapeutics
Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.